Evidence map›Paper›PMID 33253291›Full record

ArticlePLoS pathogens2020

Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection.

Brittany L Uhlorn, Robert Jackson, Shuaizhi Li, Shauna M Bratton, Koenraad Van Doorslaer, Samuel K Campos

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brittany L UhlornCancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-7293-0512
Robert JacksonSchool of Animal & Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0001-9898-5546
Shuaizhi LiDepartment of Immunobiology, The University of Arizona, Tucson, Arizona, United States of America.
Shauna M BrattonDepartment of Physiology, The University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0003-1045-3532
Koenraad Van DoorslaerCancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0002-2985-0733
Samuel K CamposCancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, Arizona, United States of America.ORCID 0000-0003-1540-9821
University of Arizona · US

Funding

Mechanisms of L2-Mediated Membrane Translocation of the Papillomaviral GenomeR01AI108751 · NIAID · UNIVERSITY OF ARIZONA · PI CAMPOS, SAMUEL K · 2014 to 2018
$1.8M
Mechanisms and Consequences of L2-Dependent Subcellular Trafficking of the HPV Genome.R01GM136853 · NIGMS · UNIVERSITY OF ARIZONA · PI CAMPOS, SAMUEL K · 2020 to 2023
$1.3M
NIAID NIH HHS R01 AI108751NIGMS NIH HHS R01 GM136853
6 · The paper itself

Abstract

Oncogenic human papillomaviruses (HPVs) replicate in differentiating epithelium, causing 5% of cancers worldwide. Like most other DNA viruses, HPV infection initiates after trafficking viral genome (vDNA) to host cell nuclei. Cells possess innate surveillance pathways to detect microbial components or physiological stresses often associated with microbial infections. One of these pathways, cGAS/STING, induces IRF3-dependent antiviral interferon (IFN) responses upon detection of cytosolic DNA. Virion-associated vDNA can activate cGAS/STING during initial viral entry and uncoating/trafficking, and thus cGAS/STING is an obstacle to many DNA viruses. HPV has a unique vesicular trafficking pathway compared to many other DNA viruses. As the capsid uncoats within acidic endosomal compartments, minor capsid protein L2 protrudes across vesicular membranes to facilitate transport of vDNA to the Golgi. L2/vDNA resides within the Golgi lumen until G2/M, whereupon vesicular L2/vDNA traffics along spindle microtubules, tethering to chromosomes to access daughter cell nuclei. L2/vDNA-containing vesicles likely remain intact until G1, following nuclear envelope reformation. We hypothesize that this unique vesicular trafficking protects HPV from cGAS/STING surveillance. Here, we investigate cGAS/STING responses to HPV infection. DNA transfection resulted in acute cGAS/STING activation and downstream IFN responses. In contrast, HPV infection elicited minimal cGAS/STING and IFN responses. To determine the role of vesicular trafficking in cGAS/STING evasion, we forced premature viral penetration of vesicular membranes with membrane-perturbing cationic lipids. Such treatment renders a non-infectious trafficking-defective mutant HPV infectious, yet susceptible to cGAS/STING detection. Overall, HPV evades cGAS/STING by its unique subcellular trafficking, a property that may contribute to establishment of infection.

Indexed as

AlphapapillomavirusBiological TransportCapsidCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseEndosomesGenome, ViralHumansInterferon Regulatory Factor-3Membrane ProteinsMutationNucleotidyltransferasesPapillomavirus InfectionsSTING ProteinVirionVirus InternalizationcGAS protein, humanCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsNucleotidyltransferasesSTING1 protein, humanSTING Protein

Identifiers

PMID33253291
PMCPMC7728285
OpenAlexW3107225468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.